Study Reveals Gaps in Guideline-Based Testosterone Prescribing for Men
A recent analysis published in *MedPage Today* found that many men receiving testosterone therapy do not undergo the recommended comprehensive hypogonadism work-up, raising concerns about adherence to clinical guidelines. According to the study, only 34% of patients evaluated for low testosterone met all criteria for a proper diagnostic assessment, including serum testosterone levels, symptom evaluation, and exclusion of secondary causes.
What Are the Guidelines for Testosterone Therapy?
The Endocrine Society’s 2023 guidelines emphasize that testosterone therapy should be initiated only after a thorough evaluation to confirm hypogonadism and rule out conditions like obesity, sleep apnea, or pituitary disorders. “Patients need a clear diagnosis before starting treatment,” said Dr. Emily Carter, an endocrinologist at the University of California, San Francisco, who was not involved in the study. “Skipping these steps can lead to unnecessary risks, including cardiovascular events and prostate issues.”
Why Are There Gaps in Testosterone Prescribing?
The *News-Medical* report highlighted systemic challenges in implementing guidelines, including time constraints during primary care visits and limited access to specialized testing. “Clinicians often rely on symptoms alone, which can be subjective,” noted Dr. Michael Torres, a urologist at the Mayo Clinic. “But without lab confirmation, treatment may be misaligned with actual hormone levels.”
Overprescription Risks and Patient Outcomes
A separate study in *Business Insider* warned that testosterone is being overprescribed to men who do not meet diagnostic criteria, with some receiving therapy for age-related declines rather than clinical hypogonadism. “Overuse can mask underlying health issues and increase risks like blood clots or prostate cancer progression,” cautioned Dr. Sarah Lin, a researcher at the National Institutes of Health.
How Can Patients Ensure They Receive Appropriate Care?
Patients considering testosterone therapy are advised to request a full work-up, including morning serum testosterone tests and a review of symptoms by a specialist. “Ask your doctor about the evidence supporting your treatment,” said Dr. Linda Nguyen, a board-certified internal medicine physician. “If you’re not receiving a clear explanation, seek a second opinion.”
What’s Next for Testosterone Treatment Standards?
Experts urge policymakers and healthcare providers to address disparities in guideline adherence. A 2022 review in *The Journal of Clinical Endocrinology & Metabolism* found that regions with higher rates of guideline-compliant care saw better patient outcomes, including improved sexual function and mood stability. “Standardizing care is critical,” said Dr. James Reed, a professor of medicine at Harvard Medical School. “This isn’t just about following rules—it’s about protecting patient safety.”